6.57
price up icon0.92%   0.06
after-market Handel nachbörslich: 6.59 0.02 +0.30%
loading
Schlusskurs vom Vortag:
$6.51
Offen:
$6.49
24-Stunden-Volumen:
4.15M
Relative Volume:
0.95
Marktkapitalisierung:
$1.58B
Einnahmen:
$386.15M
Nettoeinkommen (Verlust:
$-56.39M
KGV:
-28.57
EPS:
-0.23
Netto-Cashflow:
$-55.19M
1W Leistung:
+2.98%
1M Leistung:
+49.66%
6M Leistung:
+21.44%
1J Leistung:
+15.87%
1-Tages-Spanne:
Value
$6.38
$6.57
1-Wochen-Bereich:
Value
$6.235
$6.645
52-Wochen-Spanne:
Value
$3.21
$7.18

Ardelyx Inc Stock (ARDX) Company Profile

Name
Firmenname
Ardelyx Inc
Name
Telefon
510-745-7047
Name
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Mitarbeiter
395
Name
Twitter
@ardelyx
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
ARDX's Discussions on Twitter

Vergleichen Sie ARDX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ARDX
Ardelyx Inc
6.57 1.54B 386.15M -56.39M -55.19M -0.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-18 Fortgesetzt H.C. Wainwright Buy
2025-05-02 Herabstufung Raymond James Strong Buy → Outperform
2025-03-07 Fortgesetzt Ladenburg Thalmann Buy
2025-03-04 Eingeleitet BTIG Research Buy
2024-11-11 Herabstufung H.C. Wainwright Buy → Neutral
2024-07-02 Herabstufung Piper Sandler Overweight → Neutral
2024-04-05 Eingeleitet Leerink Partners Outperform
2023-12-18 Eingeleitet Raymond James Strong Buy
2023-09-07 Eingeleitet H.C. Wainwright Buy
2023-08-25 Hochstufung Cantor Fitzgerald Neutral → Overweight
2023-03-03 Hochstufung Wedbush Neutral → Outperform
2022-11-17 Hochstufung Piper Sandler Neutral → Overweight
2022-05-06 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-12-01 Hochstufung Ladenburg Thalmann Neutral → Buy
2021-10-14 Herabstufung Ladenburg Thalmann Buy → Neutral
2021-07-21 Herabstufung Jefferies Buy → Hold
2021-07-20 Herabstufung Piper Sandler Overweight → Neutral
2021-07-20 Herabstufung Wedbush Outperform → Neutral
2021-03-23 Eingeleitet Wedbush Outperform
2021-01-06 Eingeleitet Cantor Fitzgerald Overweight
2020-10-20 Fortgesetzt Citigroup Buy
2020-02-18 Fortgesetzt Jefferies Buy
2020-02-12 Eingeleitet Citigroup Buy
2020-02-10 Eingeleitet Cowen Outperform
2019-04-08 Eingeleitet Piper Jaffray Overweight
2018-08-24 Eingeleitet Jefferies Buy
2018-03-19 Fortgesetzt Leerink Partners Outperform
2017-11-29 Bestätigt Citigroup Buy
2017-11-22 Bestätigt Ladenburg Thalmann Buy
2017-10-17 Fortgesetzt Leerink Partners Outperform
2016-03-31 Eingeleitet Ladenburg Thalmann Buy
2016-03-09 Eingeleitet Cantor Fitzgerald Buy
2016-03-03 Eingeleitet Citigroup Buy
Alle ansehen

Ardelyx Inc Aktie (ARDX) Neueste Nachrichten

pulisher
Sep 03, 2025

Ardelyx’s Strategic Momentum in Global Markets: Evaluating Near-Term Catalysts - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Will Ardelyx Inc. price bounce be sustainableTrade Exit Summary & Risk Controlled Stock Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Regression analysis insights on Ardelyx Inc. performanceMarket Movement Recap & Real-Time Buy Zone Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will breakout in Ardelyx Inc. lead to full recoveryBreakout Watch & Step-by-Step Swing Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Leading vs lagging indicators on Ardelyx Inc. performanceWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Has Ardelyx Inc. found a price floorInsider Buying & Real-Time Buy Signal Notifications - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How Ardelyx Inc. stock performs during market volatilityTrend Reversal & Weekly Setup with High ROI Potential - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What technical models suggest about Ardelyx Inc.’s comebackMarket Activity Report & AI Driven Stock Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to interpret RSI for Ardelyx Inc. stockWeekly Profit Summary & Free Weekly Watchlist of Top Performers - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Strategies to average down on Ardelyx Inc.Quarterly Profit Summary & Long-Term Capital Growth Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ardelyx Inc. stock outlook for YEARWeekly Profit Analysis & Technical Pattern Recognition Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Live market analysis of Ardelyx Inc.Weekly Stock Report & Fast Moving Trade Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What makes Ardelyx Inc. stock price move sharplyStop Loss & Intraday High Probability Setup Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Ardelyx Inc. Testing Reversal Zone on Weekly Chart getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 02, 2025
pulisher
Sep 02, 2025

Ardelyx assumed with Strong Buy from Outperform at Raymond James - TipRanks

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 15:57:44 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 15:56:26 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Ardelyx Inc. benefit from macro trendsStop Loss & Verified Momentum Stock Watchlist - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can swing trading help recover from Ardelyx Inc. lossesJuly 2025 Retail & Verified Momentum Stock Watchlist - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

What does recent volatility data suggest for Ardelyx Inc.GDP Growth & Verified Trade Idea Suggestions - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Live Scanner Shows Breakout on Ardelyx Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr

Sep 01, 2025
pulisher
Aug 31, 2025

Is Ardelyx Inc. showing signs of accumulationWeekly Profit Report & Verified Entry Point Detection - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Why Ardelyx Inc. stock attracts strong analyst attention getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 31, 2025
pulisher
Aug 31, 2025

Earnings visualization tools for Ardelyx Inc.2025 Trading Recap & Growth Oriented Trade Recommendations - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to forecast Ardelyx Inc. trends using time seriesBond Market & Long-Term Growth Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What’s the recovery path for long term holders of Ardelyx Inc.Market Risk Report & Capital Efficiency Focused Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Ardelyx, Inc. (ARDX) Strengthens Global Reach with Kyowa Kirin Deal - MSN

Aug 31, 2025
pulisher
Aug 31, 2025

Using Bollinger Bands to evaluate Ardelyx Inc.July 2025 Recap & Expert Approved Momentum Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Visual trend scoring systems applied to Ardelyx Inc.July 2025 Movers & Accurate Intraday Trading Signals - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is Ardelyx Inc. stock poised for growthWeekly Stock Report & Low Volatility Stock Recommendations - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Will Ardelyx Inc. outperform the marketCEO Change & Weekly Market Pulse Updates - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Quant Strategy Flags Ardelyx Inc. for Entry getLinesFromResByArray error: size == 0 - 클래시안

Aug 29, 2025
pulisher
Aug 29, 2025

Ardelyx Stock (ARDX) Opinions on Insider Sale and CMS Case - Quiver Quantitative

Aug 29, 2025
pulisher
Aug 29, 2025

Multi asset correlation models including Ardelyx Inc.July 2025 Summary & Technical Pattern Based Buy Signals - Newser

Aug 29, 2025

Finanzdaten der Ardelyx Inc-Aktie (ARDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ardelyx Inc-Aktie (ARDX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Williams Laura A
Chief Patient Officer
Aug 26 '25
Sale
6.12
80,000
489,680
366,322
Kelliher Mike
Chief Business Officer
Aug 21 '25
Sale
5.93
5,417
32,132
276,741
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):